The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neurostimulation Devices Market Research Report 2024
Synopsis
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The global Neurostimulation Devices market was valued at US$ 6640 million in 2023 and is anticipated to reach US$ 14170 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
Global Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.
This report aims to provide a comprehensive presentation of the global market for Neurostimulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurostimulation Devices.
Report Scope
The Neurostimulation Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurostimulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurostimulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
Segment by Type
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurostimulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurostimulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The global Neurostimulation Devices market was valued at US$ 6640 million in 2023 and is anticipated to reach US$ 14170 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
Global Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.
This report aims to provide a comprehensive presentation of the global market for Neurostimulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurostimulation Devices.
Report Scope
The Neurostimulation Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurostimulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurostimulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
Segment by Type
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurostimulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurostimulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Neurostimulation Devices Market Overview
1.1 Product Overview and Scope of Neurostimulation Devices
1.2 Neurostimulation Devices Segment by Type
1.2.1 Global Neurostimulation Devices Market Value Comparison by Type (2024-2030)
1.2.2 Spinal Cord Stimulation (SCS)
1.2.3 Gastric Electric Stimulation (GES)
1.2.4 Deep Brain Stimulation (DBS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Vagus Nerve Stimulation (VNS)
1.2.7 Other
1.3 Neurostimulation Devices Segment by Application
1.3.1 Global Neurostimulation Devices Market Value by Application: (2024-2030)
1.3.2 Pain Management
1.3.3 Parkinson’s Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Global Neurostimulation Devices Market Size Estimates and Forecasts
1.4.1 Global Neurostimulation Devices Revenue 2019-2030
1.4.2 Global Neurostimulation Devices Sales 2019-2030
1.4.3 Global Neurostimulation Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurostimulation Devices Market Competition by Manufacturers
2.1 Global Neurostimulation Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurostimulation Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurostimulation Devices Average Price by Manufacturers (2019-2024)
2.4 Global Neurostimulation Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurostimulation Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurostimulation Devices, Product Type & Application
2.7 Neurostimulation Devices Market Competitive Situation and Trends
2.7.1 Neurostimulation Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurostimulation Devices Players Market Share by Revenue
2.7.3 Global Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurostimulation Devices Retrospective Market Scenario by Region
3.1 Global Neurostimulation Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurostimulation Devices Global Neurostimulation Devices Sales by Region: 2019-2030
3.2.1 Global Neurostimulation Devices Sales by Region: 2019-2024
3.2.2 Global Neurostimulation Devices Sales by Region: 2025-2030
3.3 Global Neurostimulation Devices Global Neurostimulation Devices Revenue by Region: 2019-2030
3.3.1 Global Neurostimulation Devices Revenue by Region: 2019-2024
3.3.2 Global Neurostimulation Devices Revenue by Region: 2025-2030
3.4 North America Neurostimulation Devices Market Facts & Figures by Country
3.4.1 North America Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurostimulation Devices Sales by Country (2019-2030)
3.4.3 North America Neurostimulation Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurostimulation Devices Market Facts & Figures by Country
3.5.1 Europe Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurostimulation Devices Sales by Country (2019-2030)
3.5.3 Europe Neurostimulation Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurostimulation Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurostimulation Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Neurostimulation Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neurostimulation Devices Market Facts & Figures by Country
3.7.1 Latin America Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurostimulation Devices Sales by Country (2019-2030)
3.7.3 Latin America Neurostimulation Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurostimulation Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurostimulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurostimulation Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurostimulation Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurostimulation Devices Sales by Type (2019-2030)
4.1.1 Global Neurostimulation Devices Sales by Type (2019-2024)
4.1.2 Global Neurostimulation Devices Sales by Type (2025-2030)
4.1.3 Global Neurostimulation Devices Sales Market Share by Type (2019-2030)
4.2 Global Neurostimulation Devices Revenue by Type (2019-2030)
4.2.1 Global Neurostimulation Devices Revenue by Type (2019-2024)
4.2.2 Global Neurostimulation Devices Revenue by Type (2025-2030)
4.2.3 Global Neurostimulation Devices Revenue Market Share by Type (2019-2030)
4.3 Global Neurostimulation Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurostimulation Devices Sales by Application (2019-2030)
5.1.1 Global Neurostimulation Devices Sales by Application (2019-2024)
5.1.2 Global Neurostimulation Devices Sales by Application (2025-2030)
5.1.3 Global Neurostimulation Devices Sales Market Share by Application (2019-2030)
5.2 Global Neurostimulation Devices Revenue by Application (2019-2030)
5.2.1 Global Neurostimulation Devices Revenue by Application (2019-2024)
5.2.2 Global Neurostimulation Devices Revenue by Application (2025-2030)
5.2.3 Global Neurostimulation Devices Revenue Market Share by Application (2019-2030)
5.3 Global Neurostimulation Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Neurostimulation Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Neurostimulation Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Neurostimulation Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Corporation Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova Neurostimulation Devices Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Nevro
6.5.1 Nevro Corporation Information
6.5.2 Nevro Description and Business Overview
6.5.3 Nevro Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nevro Neurostimulation Devices Product Portfolio
6.5.5 Nevro Recent Developments/Updates
6.6 NeuroPace
6.6.1 NeuroPace Corporation Information
6.6.2 NeuroPace Description and Business Overview
6.6.3 NeuroPace Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeuroPace Neurostimulation Devices Product Portfolio
6.6.5 NeuroPace Recent Developments/Updates
6.7 Beijing Pins
6.6.1 Beijing Pins Corporation Information
6.6.2 Beijing Pins Description and Business Overview
6.6.3 Beijing Pins Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Pins Neurostimulation Devices Product Portfolio
6.7.5 Beijing Pins Recent Developments/Updates
6.8 Synapse Biomedical
6.8.1 Synapse Biomedical Corporation Information
6.8.2 Synapse Biomedical Description and Business Overview
6.8.3 Synapse Biomedical Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Synapse Biomedical Neurostimulation Devices Product Portfolio
6.8.5 Synapse Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurostimulation Devices Industry Chain Analysis
7.2 Neurostimulation Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurostimulation Devices Production Mode & Process
7.4 Neurostimulation Devices Sales and Marketing
7.4.1 Neurostimulation Devices Sales Channels
7.4.2 Neurostimulation Devices Distributors
7.5 Neurostimulation Devices Customers
8 Neurostimulation Devices Market Dynamics
8.1 Neurostimulation Devices Industry Trends
8.2 Neurostimulation Devices Market Drivers
8.3 Neurostimulation Devices Market Challenges
8.4 Neurostimulation Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
